Skip to main content
Top
Published in: Endocrine 1/2017

01-01-2017 | Mini Review

Gynecomastia and hormones

Authors: Andrea Sansone, Francesco Romanelli, Massimiliano Sansone, Andrea Lenzi, Luigi Di Luigi

Published in: Endocrine | Issue 1/2017

Login to get access

Abstract

Gynecomastia—the enlargement of male breast tissue in men—is a common finding, frequently observed in newborns, adolescents, and old men. Physiological gynecomastia, occurring in almost 25 % of cases, is benign and self-limited; on the other hand, several conditions and drugs may induce proliferation of male breast tissue. True gynecomastia is a common feature often related to estrogen excess and/or androgen deficiency as a consequence of different endocrine disorders. Biochemical evaluation should be performed once physiological or iatrogenic gynecomastia has been ruled out. Non-endocrine illnesses, including liver failure and chronic kidney disease, are another cause of gynecomastia which should be considered. Treating the underlying disease or discontinuing medications might resolve gynecomastia, although the psychosocial burden of this condition might require different and careful consideration.
Literature
4.
go back to reference R. Mathur, G.D. Braunstein, Gynecomastia: pathomechanisms and treatment strategies. Horm. Res. 48(3), 95–102 (1997)CrossRefPubMed R. Mathur, G.D. Braunstein, Gynecomastia: pathomechanisms and treatment strategies. Horm. Res. 48(3), 95–102 (1997)CrossRefPubMed
6.
go back to reference M. Kipling, J.E. Ralph, K. Callanan, Psychological impact of male breast disorders: literature review and survey results. Breast Care (Basel) 9(1), 29–33 (2014). doi:10.1159/000358751 CrossRef M. Kipling, J.E. Ralph, K. Callanan, Psychological impact of male breast disorders: literature review and survey results. Breast Care (Basel) 9(1), 29–33 (2014). doi:10.​1159/​000358751 CrossRef
10.
go back to reference E. Sloand, Pediatric and adolescent breast health. Lippincotts Prim. Care Pract. 2(2), 170–175 (1998)PubMed E. Sloand, Pediatric and adolescent breast health. Lippincotts Prim. Care Pract. 2(2), 170–175 (1998)PubMed
11.
go back to reference G. Dickson, Gynecomastia. Am. Fam. Physician 85(7), 716–722 (2012)PubMed G. Dickson, Gynecomastia. Am. Fam. Physician 85(7), 716–722 (2012)PubMed
12.
13.
go back to reference R.S. Swerdloff, J. Ng, Gynecomastia: etiology, diagnosis, and treatment, in Endotext, ed. by L.J. De Groot, P. Beck-Peccoz, G. Chrousos, K. Dungan, A. Grossman, J.M. Hershman, C. Koch, R. McLachlan, M. New, R. Rebar, F. Singer, A. Vinik, M.O. Weickert (MDText.com, Inc, South Dartmouth, MA, 2000) R.S. Swerdloff, J. Ng, Gynecomastia: etiology, diagnosis, and treatment, in Endotext, ed. by L.J. De Groot, P. Beck-Peccoz, G. Chrousos, K. Dungan, A. Grossman, J.M. Hershman, C. Koch, R. McLachlan, M. New, R. Rebar, F. Singer, A. Vinik, M.O. Weickert (MDText.com, Inc, South Dartmouth, MA, 2000)
14.
go back to reference N. Rokutanda, T. Iwasaki, H. Odawara, R. Nagaoka, W. Miyazaki, A. Takeshita, Y. Koibuchi, J. Horiguchi, N. Shimokawa, Y. Iino, Y. Morishita, N. Koibuchi, Augmentation of estrogen receptor-mediated transcription by steroid and xenobiotic receptor. Endocrine 33(3), 305–316 (2008). doi:10.1007/s12020-008-9091-9 CrossRefPubMed N. Rokutanda, T. Iwasaki, H. Odawara, R. Nagaoka, W. Miyazaki, A. Takeshita, Y. Koibuchi, J. Horiguchi, N. Shimokawa, Y. Iino, Y. Morishita, N. Koibuchi, Augmentation of estrogen receptor-mediated transcription by steroid and xenobiotic receptor. Endocrine 33(3), 305–316 (2008). doi:10.​1007/​s12020-008-9091-9 CrossRefPubMed
15.
go back to reference S.A. Bembo, H.E. Carlson, Gynecomastia: its features, and when and how to treat it. Clevel. Clin. J. Med. 71(6), 511–517 (2004)CrossRef S.A. Bembo, H.E. Carlson, Gynecomastia: its features, and when and how to treat it. Clevel. Clin. J. Med. 71(6), 511–517 (2004)CrossRef
16.
go back to reference R.N. Morcos, T. Kizy, Gynecomastia: when is treatment indicated? J. Fam. Pract. 61(12), 719–725 (2012)PubMed R.N. Morcos, T. Kizy, Gynecomastia: when is treatment indicated? J. Fam. Pract. 61(12), 719–725 (2012)PubMed
20.
go back to reference M. Galdiero, R. Pivonello, L.F. Grasso, A. Cozzolino, A. Colao, Growth hormone, prolactin, and sexuality. J. Endocrinol. Investig. 35(8), 782–794 (2012). doi:10.1007/BF03345805 CrossRef M. Galdiero, R. Pivonello, L.F. Grasso, A. Cozzolino, A. Colao, Growth hormone, prolactin, and sexuality. J. Endocrinol. Investig. 35(8), 782–794 (2012). doi:10.​1007/​BF03345805 CrossRef
25.
go back to reference R.C. Hovey, J.F. Trott, E. Ginsburg, A. Goldhar, M.M. Sasaki, S.J. Fountain, K. Sundararajan, B.K. Vonderhaar, Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Dev. Dyn. 222(2), 192–205 (2001). doi:10.1002/dvdy.1179 CrossRefPubMed R.C. Hovey, J.F. Trott, E. Ginsburg, A. Goldhar, M.M. Sasaki, S.J. Fountain, K. Sundararajan, B.K. Vonderhaar, Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Dev. Dyn. 222(2), 192–205 (2001). doi:10.​1002/​dvdy.​1179 CrossRefPubMed
26.
go back to reference M.L. Bravo, M.P. Pinto, I. Gonzalez, B. Oliva, S. Kato, M.A. Cuello, C.A. Lange, G.I. Owen, Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor. Endocrine 48(1), 309–320 (2015). doi:10.1007/s12020-014-0288-9 CrossRefPubMed M.L. Bravo, M.P. Pinto, I. Gonzalez, B. Oliva, S. Kato, M.A. Cuello, C.A. Lange, G.I. Owen, Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor. Endocrine 48(1), 309–320 (2015). doi:10.​1007/​s12020-014-0288-9 CrossRefPubMed
28.
go back to reference S. Kayemba-Kays, G. Fromont-Hankard, G. Lettelier, S. Gabriel, G. Levard, Leydig cell tumour revealed by bilateral gynecomastia in a 15-year-old adolescent: a patient report. J. Pediatr. Endocrinol. Metab. 23(11), 1195–1199 (2010)PubMed S. Kayemba-Kays, G. Fromont-Hankard, G. Lettelier, S. Gabriel, G. Levard, Leydig cell tumour revealed by bilateral gynecomastia in a 15-year-old adolescent: a patient report. J. Pediatr. Endocrinol. Metab. 23(11), 1195–1199 (2010)PubMed
30.
go back to reference N. Kolitsas, S. Tsambalas, F. Dimitriadis, D. Baltogiannis, E. Vlachopoulou, S. Vappa, D. Giannakis, P. Tsounapi, A. Takenaka, N. Sofikitis, Gynecomastia as a first clinical sign of nonseminomatous germ cell tumor. Urol. Int. 87(2), 248–250 (2011). doi:10.1159/000328387 CrossRefPubMed N. Kolitsas, S. Tsambalas, F. Dimitriadis, D. Baltogiannis, E. Vlachopoulou, S. Vappa, D. Giannakis, P. Tsounapi, A. Takenaka, N. Sofikitis, Gynecomastia as a first clinical sign of nonseminomatous germ cell tumor. Urol. Int. 87(2), 248–250 (2011). doi:10.​1159/​000328387 CrossRefPubMed
36.
go back to reference M.G. Forest, A. Lecoq, J.M. Saez, Kinetics of human chorionic gonadotropin-induced steroidogenic response of the human testis. II. Plasma 17 α-hydroxyprogesterone, δ4-androstenedione, estrone, and 17 β-estradiol: evidence for the action of human chorionic gonadotropin on intermediate enzymes implicated in steroid biosynthesis. J. Clin. Endocrinol. Metab. 49(2), 284–291 (1979). doi:10.1210/jcem-49-2-284 CrossRefPubMed M.G. Forest, A. Lecoq, J.M. Saez, Kinetics of human chorionic gonadotropin-induced steroidogenic response of the human testis. II. Plasma 17 α-hydroxyprogesterone, δ4-androstenedione, estrone, and 17 β-estradiol: evidence for the action of human chorionic gonadotropin on intermediate enzymes implicated in steroid biosynthesis. J. Clin. Endocrinol. Metab. 49(2), 284–291 (1979). doi:10.​1210/​jcem-49-2-284 CrossRefPubMed
38.
go back to reference K.L. Becker, J.L. Winnacker, M.J. Matthews, G.A. Higgins Jr, Gynecomastia and hyperthyroidism. An endocrine and histological investigation. J. Clin. Endocrinol. Metab. 28(2), 277–285 (1968). doi:10.1210/jcem-28-2-277 CrossRefPubMed K.L. Becker, J.L. Winnacker, M.J. Matthews, G.A. Higgins Jr, Gynecomastia and hyperthyroidism. An endocrine and histological investigation. J. Clin. Endocrinol. Metab. 28(2), 277–285 (1968). doi:10.​1210/​jcem-28-2-277 CrossRefPubMed
39.
go back to reference H.K. Ho, K.C. Loh, Hyperthyroidism with gynaecomastia as the initial complaint: a case report. Ann. Acad. Med. Singapore 27(4), 594–596 (1998)PubMed H.K. Ho, K.C. Loh, Hyperthyroidism with gynaecomastia as the initial complaint: a case report. Ann. Acad. Med. Singapore 27(4), 594–596 (1998)PubMed
40.
go back to reference W.B. Chan, V.T. Yeung, C.C. Chow, W.Y. So, C.S. Cockram, Gynaecomastia as a presenting feature of thyrotoxicosis. Postgrad. Med. J. 75(882), 229–231 (1999)CrossRefPubMedPubMedCentral W.B. Chan, V.T. Yeung, C.C. Chow, W.Y. So, C.S. Cockram, Gynaecomastia as a presenting feature of thyrotoxicosis. Postgrad. Med. J. 75(882), 229–231 (1999)CrossRefPubMedPubMedCentral
44.
go back to reference M. Caprio, E. Fabbrini, A.M. Isidori, A. Aversa, A. Fabbri, Leptin in reproduction. Trends Endocrinol. Metab. 12(2), 65–72 (2001)CrossRefPubMed M. Caprio, E. Fabbrini, A.M. Isidori, A. Aversa, A. Fabbri, Leptin in reproduction. Trends Endocrinol. Metab. 12(2), 65–72 (2001)CrossRefPubMed
48.
go back to reference B. Dundar, N. Dundar, T. Erci, E. Bober, A. Buyukgebiz, Leptin levels in boys with pubertal gynecomastia. J. Pediatr. Endocrinol. Metab. 18(10), 929–934 (2005)CrossRefPubMed B. Dundar, N. Dundar, T. Erci, E. Bober, A. Buyukgebiz, Leptin levels in boys with pubertal gynecomastia. J. Pediatr. Endocrinol. Metab. 18(10), 929–934 (2005)CrossRefPubMed
50.
go back to reference S. Catalano, S. Marsico, C. Giordano, L. Mauro, P. Rizza, M.L. Panno, S. Ando, Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. J. Biol. Chem. 278(31), 28668–28676 (2003). doi:10.1074/jbc.M301695200 CrossRefPubMed S. Catalano, S. Marsico, C. Giordano, L. Mauro, P. Rizza, M.L. Panno, S. Ando, Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. J. Biol. Chem. 278(31), 28668–28676 (2003). doi:10.​1074/​jbc.​M301695200 CrossRefPubMed
51.
go back to reference S. Catalano, L. Mauro, S. Marsico, C. Giordano, P. Rizza, V. Rago, D. Montanaro, M. Maggiolini, M.L. Panno, S. Ando, Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells. J. Biol. Chem. 279(19), 19908–19915 (2004). doi:10.1074/jbc.M313191200 CrossRefPubMed S. Catalano, L. Mauro, S. Marsico, C. Giordano, P. Rizza, V. Rago, D. Montanaro, M. Maggiolini, M.L. Panno, S. Ando, Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells. J. Biol. Chem. 279(19), 19908–19915 (2004). doi:10.​1074/​jbc.​M313191200 CrossRefPubMed
52.
go back to reference M.N. Dieudonne, A. Sammari, E. Dos Santos, M.C. Leneveu, Y. Giudicelli, R. Pecquery, Sex steroids and leptin regulate 11 β-hydroxysteroid dehydrogenase I and P450 aromatase expressions in human preadipocytes: sex specificities. J. Steroid Biochem. Mol. Biol. 99(4–5), 189–196 (2006). doi:10.1016/j.jsbmb.2006.01.007 CrossRefPubMed M.N. Dieudonne, A. Sammari, E. Dos Santos, M.C. Leneveu, Y. Giudicelli, R. Pecquery, Sex steroids and leptin regulate 11 β-hydroxysteroid dehydrogenase I and P450 aromatase expressions in human preadipocytes: sex specificities. J. Steroid Biochem. Mol. Biol. 99(4–5), 189–196 (2006). doi:10.​1016/​j.​jsbmb.​2006.​01.​007 CrossRefPubMed
53.
go back to reference B. Lapauw, G. T’Sjoen, A. Mahmoud, J.M. Kaufman, J.B. Ruige, Short-term aromatase inhibition: effects on glucose metabolism and serum leptin levels in young and elderly men. Eur. J. Endocrinol. 160(3), 397–402 (2009). doi:10.1530/EJE-08-0881 CrossRefPubMed B. Lapauw, G. T’Sjoen, A. Mahmoud, J.M. Kaufman, J.B. Ruige, Short-term aromatase inhibition: effects on glucose metabolism and serum leptin levels in young and elderly men. Eur. J. Endocrinol. 160(3), 397–402 (2009). doi:10.​1530/​EJE-08-0881 CrossRefPubMed
55.
go back to reference S.T. Ng, J. Zhou, O.O. Adesanya, J. Wang, D. LeRoith, C.A. Bondy, Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat. Med. 3(10), 1141–1144 (1997)CrossRefPubMed S.T. Ng, J. Zhou, O.O. Adesanya, J. Wang, D. LeRoith, C.A. Bondy, Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat. Med. 3(10), 1141–1144 (1997)CrossRefPubMed
56.
go back to reference M.G. Mieritz, K. Sorensen, L. Aksglaede, A. Mouritsen, C.P. Hagen, L. Hilsted, A.M. Andersson, A. Juul, Elevated serum IGF-I, but unaltered sex steroid levels, in healthy boys with pubertal gynaecomastia. Clin. Endocrinol. (Oxf.) 80(5), 691–698 (2014). doi:10.1111/cen.12323 CrossRef M.G. Mieritz, K. Sorensen, L. Aksglaede, A. Mouritsen, C.P. Hagen, L. Hilsted, A.M. Andersson, A. Juul, Elevated serum IGF-I, but unaltered sex steroid levels, in healthy boys with pubertal gynaecomastia. Clin. Endocrinol. (Oxf.) 80(5), 691–698 (2014). doi:10.​1111/​cen.​12323 CrossRef
57.
go back to reference L.J. De Groot, P. Beck-Peccoz, G. Chrousos, K. Dungan, A. Grossman, J.M. Hershman, C. Koch, R. McLachlan, M. New, R. Rebar, F. Singer, A. Vinik, M.O. Weickert, R.S. Swerdloff, J. Ng, Gynecomastia: etiology, diagnosis, and treatment, vol. 53 (MDText.com, Inc, South Dartmouth, MA, 2000) L.J. De Groot, P. Beck-Peccoz, G. Chrousos, K. Dungan, A. Grossman, J.M. Hershman, C. Koch, R. McLachlan, M. New, R. Rebar, F. Singer, A. Vinik, M.O. Weickert, R.S. Swerdloff, J. Ng, Gynecomastia: etiology, diagnosis, and treatment, vol. 53 (MDText.com, Inc, South Dartmouth, MA, 2000)
58.
go back to reference M.G. Mieritz, L.L. Raket, C.P. Hagen, J.E. Nielsen, M.L. Talman, J.H. Petersen, S.H. Sommer, K.M. Main, N. Jorgensen, A. Juul, A longitudinal study of growth, sex steroids, and IGF-1 in boys with physiological gynecomastia. J. Clin. Endocrinol. Metab. 100(10), 3752–3759 (2015). doi:10.1210/jc.2015-2836 CrossRefPubMed M.G. Mieritz, L.L. Raket, C.P. Hagen, J.E. Nielsen, M.L. Talman, J.H. Petersen, S.H. Sommer, K.M. Main, N. Jorgensen, A. Juul, A longitudinal study of growth, sex steroids, and IGF-1 in boys with physiological gynecomastia. J. Clin. Endocrinol. Metab. 100(10), 3752–3759 (2015). doi:10.​1210/​jc.​2015-2836 CrossRefPubMed
59.
go back to reference F.M. Souza, P.F. Collett-Solberg, Adverse effects of growth hormone replacement therapy in children. Arq. Bras. Endocrinol. Metab. 55(8), 559–565 (2011)CrossRef F.M. Souza, P.F. Collett-Solberg, Adverse effects of growth hormone replacement therapy in children. Arq. Bras. Endocrinol. Metab. 55(8), 559–565 (2011)CrossRef
60.
go back to reference H. Liu, D.M. Bravata, I. Olkin, S. Nayak, B. Roberts, A.M. Garber, A.R. Hoffman, Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann. Intern. Med. 146(2), 104–115 (2007)CrossRefPubMed H. Liu, D.M. Bravata, I. Olkin, S. Nayak, B. Roberts, A.M. Garber, A.R. Hoffman, Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann. Intern. Med. 146(2), 104–115 (2007)CrossRefPubMed
63.
go back to reference M. Derkacz, I. Chmiel-Perzynska, A. Nowakowski, Gynecomastia—a difficult diagnostic problem. Endokrynol. Pol. 62(2), 190–202 (2011)PubMed M. Derkacz, I. Chmiel-Perzynska, A. Nowakowski, Gynecomastia—a difficult diagnostic problem. Endokrynol. Pol. 62(2), 190–202 (2011)PubMed
64.
go back to reference M. Sinclair, M. Grossmann, P.J. Gow, P.W. Angus, Testosterone in men with advanced liver disease: abnormalities and implications. J. Gastroenterol. Hepatol. 30(2), 244–251 (2015). doi:10.1111/jgh.12695 CrossRefPubMed M. Sinclair, M. Grossmann, P.J. Gow, P.W. Angus, Testosterone in men with advanced liver disease: abnormalities and implications. J. Gastroenterol. Hepatol. 30(2), 244–251 (2015). doi:10.​1111/​jgh.​12695 CrossRefPubMed
65.
68.
go back to reference L. Di Luigi, F. Romanelli, A. Lenzi, Androgenic–anabolic steroids abuse in males. J. Endocrinol. Investig. 28(3 Suppl), 81–84 (2005) L. Di Luigi, F. Romanelli, A. Lenzi, Androgenic–anabolic steroids abuse in males. J. Endocrinol. Investig. 28(3 Suppl), 81–84 (2005)
70.
go back to reference E. Nieschlag, E. Vorona, Mechanisms in endocrinology: medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur. J. Endocrinol. 173(2), R47–R58 (2015). doi:10.1530/EJE-15-0080 CrossRefPubMed E. Nieschlag, E. Vorona, Mechanisms in endocrinology: medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur. J. Endocrinol. 173(2), R47–R58 (2015). doi:10.​1530/​EJE-15-0080 CrossRefPubMed
77.
go back to reference A. Vivacqua, A.G. Recchia, G. Fasanella, S. Gabriele, A. Carpino, V. Rago, M.L. Di Gioia, A. Leggio, D. Bonofiglio, A. Liguori, M. Maggiolini, The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells. Endocrine 22(3), 275–284 (2003). doi:10.1385/ENDO:22:3:275 CrossRefPubMed A. Vivacqua, A.G. Recchia, G. Fasanella, S. Gabriele, A. Carpino, V. Rago, M.L. Di Gioia, A. Leggio, D. Bonofiglio, A. Liguori, M. Maggiolini, The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells. Endocrine 22(3), 275–284 (2003). doi:10.​1385/​ENDO:​22:​3:​275 CrossRefPubMed
79.
go back to reference L.R. Chadwick, D. Nikolic, J.E. Burdette, C.R. Overk, J.L. Bolton, R.B. van Breemen, R. Frohlich, H.H. Fong, N.R. Farnsworth, G.F. Pauli, Estrogens and congeners from spent hops (Humulus lupulus). J. Nat. Prod. 67(12), 2024–2032 (2004). doi:10.1021/np049783i CrossRefPubMed L.R. Chadwick, D. Nikolic, J.E. Burdette, C.R. Overk, J.L. Bolton, R.B. van Breemen, R. Frohlich, H.H. Fong, N.R. Farnsworth, G.F. Pauli, Estrogens and congeners from spent hops (Humulus lupulus). J. Nat. Prod. 67(12), 2024–2032 (2004). doi:10.​1021/​np049783i CrossRefPubMed
80.
go back to reference R.D. Goldman, Drug-induced gynecomastia in children and adolescents. Can. Fam. Phys. 56(4), 344–345 (2010) R.D. Goldman, Drug-induced gynecomastia in children and adolescents. Can. Fam. Phys. 56(4), 344–345 (2010)
81.
go back to reference M.A. Sauer, S.M. Rifka, R.L. Hawks, G.B. Cutler Jr, D.L. Loriaux, Marijuana: interaction with the estrogen receptor. J. Pharmacol. Exp. Ther. 224(2), 404–407 (1983)PubMed M.A. Sauer, S.M. Rifka, R.L. Hawks, G.B. Cutler Jr, D.L. Loriaux, Marijuana: interaction with the estrogen receptor. J. Pharmacol. Exp. Ther. 224(2), 404–407 (1983)PubMed
Metadata
Title
Gynecomastia and hormones
Authors
Andrea Sansone
Francesco Romanelli
Massimiliano Sansone
Andrea Lenzi
Luigi Di Luigi
Publication date
01-01-2017
Publisher
Springer US
Published in
Endocrine / Issue 1/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-0975-9

Other articles of this Issue 1/2017

Endocrine 1/2017 Go to the issue